Document:

Exhibit 10.8

 

SENIOR PROMISSORY NOTE

 

	US$500,000	June 17, 2015

 

For value received, Mariposa Health, Inc.,
a Delaware corporation and Mariposa Health Limited, an Australian corporation (“Makers”) hereby, jointly
and severally, promise to pay to the order of PTS, Inc. or its assigns (the “Holder”), upon the earlier
of (i) no later than October 15, 2015 ("Maturity"), or (ii) an Event of Default (as defined below), the
principal amount of US$500,000.00, or such amount advanced or outstanding hereunder, plus interest in arrears from and including
the date hereof on the principal balance from time to time outstanding, at a rate per annum equal to ten percent (10%). This Senior
Promissory Note (this "Note") may be prepaid in whole or in part. This Note shall be senior to all other
debt of the Makers. Interest shall be calculated on the basis of actual number of days elapsed over a year of 365 days. Notwithstanding
any other provision of this Note, the Holder does not intend to charge, and the Makers shall not be required to pay, any interest
or other fees or charges in excess of the maximum permitted by applicable law; any payments in excess of such maximum shall be
refunded to the Makers or credited to reduce the principal hereunder. All payments received by the Holder will be applied first
to costs of collection, if any, then to interest and the balance to principal. This Note is intended to be drawn down in such amounts
as needed by Maker subject to a maximum net amount of total cash of $410,000.00 as a result of a commission of $40,000.00 being
paid to the broker of this Note and $50,000.00 having being paid by the broker of this Note on December 3, 2014 to counsel for
Mariposa Health, Inc. to pay its expenses in connection with it going public through a reverse merger with Mariposa Health Limited.
The minimum and initial drawn down amount will be $300,000, which, net of the above fees and expenses, equals $210,000.00, and
shall be transferred in two tranches as follows on the date of this Note:

 

$150,000.00 to

 

Mariposa Health Limited

Westpac Bank

BSB:  032 095

Acc:  218 331

Swift:  WPACAU2S

 

$60,000.00 to

 

Mariposa Health Limited

Westpac Bank

BSB:  034 702

Acc.:  019 166

Swift:  WPACAU2S

 

. All references in this Note to dollars
are to U.S. dollars and not Australian dollars.

 

    	 

    	 

    

 

Payments of principal
and interest will be made by check in immediately available funds or by wire transfer sent to the Holder at the address furnished
to the Makers for that purpose.

 

This Note shall entitle
the Holder to receive upon issuance of the Note a warrant in the form attached hereto as Exhibit A, exercisable for
five (5) years, at an exercise price equal to $0.001 per share, to purchase up to 400,000 shares of the common stock, par value
$0.001 per share ("Common Stock"), of Mariposa Health, Inc.

 

1.  Events of Default.
The outstanding principal and accrued interest on this Note shall, at the option of the Holder hereof, become due and payable without
notice or demand, upon the occurrence of any one of the following specified events (each event referred to as “Event of Default”):

 

(a) failure to pay
any amount when due as herein set forth;

 

(b) default in the
performance by Makers of any material obligation to the Holder under this Note, which default is not cured within thirty (30) days
after written notice of such default from the Holder;

 

(c) the making of a general assignment
for the benefit of creditors;

 

(d) the filing of any
petition or the commencement of any proceeding by Makers of this Note for any relief under any bankruptcy or insolvency laws, or
any laws relating to the relief of debtors, readjustment of indebtedness, reorganizations, compositions, or extensions;

 

(e) the filing of any
petition or the commencement of any proceeding against Makers of this Note for any relief under any bankruptcy or insolvency laws,
or any laws relating to the relief of debtors, readjustment of indebtedness, reorganizations, compositions, or extensions, which
proceeding is not dismissed within sixty (60) days; or

 

(f) the past or future
making of a materially false representation or warranty by Makers in connection with this Note.

 

2.  Default Interest
Rate. The default interest rate shall be 15% per annum.

 

3.  Expenses of Collection.
Makers agree to pay the Holder's costs in collecting and enforcing this Note, including attorney's fees.

 

4.  Waiver by the
Holder. No waiver of any obligation of Makers under this Note shall be effective unless it is in a writing signed by the Holder.
A waiver by the Holder of any right or remedy under this Note on any occasion shall not be a bar to exercise of the same right
or remedy on any subsequent occasion or of any other right or remedy at any time.

 

    	- 2 -

    	 

    

 

5.  Conditions to
Financing. Prior to providing this loan, Makers shall provide to the Holder, upon request by the Holder, certificates of good
standing and qualification to do business, and the Holder shall have completed its due diligence of Makers.

 

6.  Notice. Any
notice required or permitted under this Note shall be in writing and shall be deemed to have been given on the date of delivery,
if personally delivered to the party to whom notice is to be given, or on the fifth business day after mailing, if mailed to the
party to whom notice is to be given, by certified mail, return receipt requested, postage prepaid, or overnight courier service
with proof of receipt, and addressed as follows:

 

	If to the Maker:	
        Mariposa Health, Inc.

        Mariposa Health Limited

        888 Prospect Street

        La Jolla, CA 92037

        Attn: Dr. Phillip Comans, President

        Email: pcomans@mariposahealth.com.au

	 	 
	With a copy to:	Akerman LLP
	 	750 9th Street, N.W., Suite 700
	 	Washington, D.C. 20001
	 	Attention:        Ernest M. Stern, Esq.
	 	Telephone:      (202) 824-1705 
	 	Facsimile:         (866) 268-2788  

 

	If to the Holder:	PTS, Inc.
	 	28494 Westinghouse Place, Suite 213
	 	Valencia, CA 91355
	 	 
	With a copy to:	McDowell Odom LLP
	 	28494 Westinghouse Place Suite 305
	 	Valencia CA 91355
	 	Attention: Claudia J. McDowell, Esq.
	 	(661) 449-9630
	 	(818) 475-1819 Facsimile
	 	claudia@mcdowellodom.com

 

7.  Waiver by the
Makers. Makers hereby expressly waive presentment, demand and protest, notice of demand, dishonor and nonpayment of this Note,
and all other notices or demands of any kind in connection with the delivery, acceptance, performance, default or enforcement hereof,
and hereby consents to any delays, extensions of time, renewals, waivers or modifications that may be granted or consented to by
the Holder hereof with respect to the time of payment or any other provision hereof.

 

    	- 3 -

    	 

    

 

8.  Severability.
In the event any one or more of the provisions of this Note shall for any reason be held to be invalid, illegal or unenforceable,
in whole or in part or in any respect, or in the event that any one or more of the provisions of this Note operate or would prospectively
operate to invalidate this Note, then and in any such event, such provision(s) only shall be deemed null and void and shall not
affect any other provision of this Note and the remaining provisions of this Note shall remain operative and in full force and
effect and in no way shall be affected, prejudiced, or disturbed thereby.

 

9.  Joint and Several
Liability. If this Note is executed by more than one person or entity as Maker, the obligations of each person or entity will
be joint and several. No person or entity will be a mere accommodation maker, but each will be primarily and directly liable. Each
borrower waives presentment; demand; notice of dishonor; notice of default or delinquency; notice of acceleration; notice of protest
and nonpayment; notice of costs, expenses, or losses and interest; notice of interest on interest and late charges; and diligence
in taking any action to collect any sums owing under this Note or in proceeding against any of the rights or interests to properties
securing payment of this Note.

 

10.  Governing Law.
This Note will be construed and enforced in accordance with Nevada law, except to the extent that Federal laws pre-empt state law,
and all persons and entities in any manner obligated under this Note consent to the jurisdiction of any Federal or State Court
within Nevada having proper venue and also consent to service of process by any means authorized by Nevada or Federal law.

 

11.  Time
of the Essence. Time is of the essence with respect to this Note and each and every provision hereof.

 

12. Binding Nature.
The provisions of this Note shall be binding upon the Makers and the heirs, personal representatives, successors and permitted
assigns of the Makers, and shall inure to the benefit of the Holder and any assignee of all or any portion of this Note, and Holder’s
respective successors and assigns.

 

13.  Amendments.
No amendment, modification, change, waiver, release or discharge hereof and hereunder shall be effective unless evidenced by
an instrument in writing and signed by the party against whom enforcement is sought.

 

[Signature Page Follows]

 

    	- 4 -

    	 

    

 

	 	MARIPOSA HEALTH, INC.
	 	 
	 	 
	 	By: Phillip Comans
	 	Title: President
	 	 
	 	MARIPOSA HEALTH LIMITED
	 	 
	 	 
	 	By: Phillip Comans
	 	Title: President

 

[Signature Page to the Mariposa Promissory
Note for Bridge Financing] 

 

    	- 5 -

    	 

    

 

Exhibit A

 

FORM OF WARRANT

 

    	- 6 -Exhibit 10.9

 

EXECUTIVE EMPLOYMENT AGREEMENT

 

This Executive Employment
Agreement (this “Agreement”) is made as of the 24th day of June, 2015 by and between Mariposa Health, Inc.,
a Delaware corporation (the “Company”), and Phillip E. Comans, a natural person who resides in Australia (“Executive”).

 

WHEREAS, the Company
wishes to employ Executive as its President and Chief Executive Officer ("CEO") and Executive wishes to accept such employment;

 

WHEREAS, the Company
and Executive wish to set forth the terms of Executive’s employment and certain additional agreements between Executive and
the Company.

 

NOW, THEREFORE, in
consideration of the foregoing recitals and the representations, covenants and terms contained herein, the parties hereto agree
as follows:

 

		1.	Employment Period

 

The Company will employ
Executive, and Executive will serve the Company, under the terms of this Agreement commencing April 30, 2015 (the “Commencement
Date”) for a term of five (5) years unless earlier terminated under Section 4 hereof. The period of time between the commencement
and the termination of Executive’s employment hereunder shall be referred to herein as the “Employment Period”.

 

		2.	Duties and Status

 

The Company hereby engages
Executive as its President and CEO on the terms and conditions set forth in this Agreement including the terms and conditions of
the Executive Proprietary Information, Inventions, and Non-Competition Agreement attached hereto as Exhibit A and incorporated
herein. Executive agrees to perform such duties as are customarily performed by similar executive officers at peer companies and
as may be more specifically enumerated from time to time by the Company’s Board of Directors (the “Board”). During
the term of the Employment Period, Executive shall exercise such authority, perform such executive functions and discharge such
responsibilities as are reasonably associated with Executive’s position, commensurate with the authority vested in Executive
pursuant to this Agreement and consistent with the governing documents of the Company.

 

		3.	Compensation and Benefits

 

		(a)	Salary. During the Employment Period, the Company shall pay to Executive, as compensation
for the performance of Executive’s duties and obligations under this Agreement, a base salary of $300,000 per annum (the
“Annual Base Salary”), payable in accordance with the Company’s regular payroll practices. Executive's Annual
Base Salary shall be reviewed annually in accordance with the policies of the Company from time to time and may be subject to upward
adjustment based upon, among other things, Executive's performance, as determined in the sole discretion of the Board. On each
annual anniversary of the Commencement Date of this Agreement, Executive's Annual Base Salary shall be subject to an annual cost
of living increase of not less than five percent (5%), provided, however, that the Board must make an affirmative
determination that such a cost of living adjustment is appropriate.

 

    	 

    	 

    

 

		(b)	Bonus. During the Employment Period, Executive shall be eligible for a bonus to be paid
in cash, stock or stock options or a combination based on performance targets that shall be defined and agreed upon mutually by
the Board and Executive. Cash and/or stock/stock option bonus payments will be determined and approved by the Board.

 

		(c)	Equity. Executive shall be eligible to receive awards of restricted stock, stock options,
stock appreciation rights, phantom stock units and such other forms of equity compensation awards that may be authorized from time
to time by the Board (collectively, “Equity”) under the Company’s equity compensation plans, such awards to be
made by the Board from time to time in its sole discretion.

 

		(d)	Other Benefits. During the Employment Period, Executive shall be entitled to participate
in all of the employee benefit plans, programs and arrangements of the Company in effect during the Employment Period which are
generally available to senior executives of the Company, subject to and on a basis consistent with the terms, conditions and overall
administration of such plans, programs and arrangements. In addition, during the Employment Period, Executive shall be entitled
to fringe benefits and perquisites comparable to those of other senior executives of the Company including, but not limited to,
standard holidays, twenty (20) days of vacation for the first year of the Employment Period and an additional day of vacation for
each year thereafter to a maximum of twenty-five (25) days, to be used in accordance with the Company’s vacation pay policy
for senior executives.

 

		(e)	Business Expenses. During the Employment Period, the Company shall promptly reimburse Executive
for all appropriately documented, reasonable business expenses incurred by Executive in the performance of Executive’s duties
under this Agreement, including telecommunications expenses and travel expenses.

 

		4.	Termination of Employment

 

		(a)	Termination for Cause. The Company may terminate Executive’s employment hereunder
for Cause (defined below). For purposes of this Agreement and subject to Executive’s opportunity to cure as provided in Section
4(c) hereof, the Company shall have Cause to terminate Executive’s employment hereunder if such termination shall be the
result of:

 

    	2

    	 

    

 

		(i)	a material breach of fiduciary duty or material breach of the terms
of this Agreement or any other agreement between Executive and the Company (including without limitation any agreements regarding
confidentiality, inventions assignment and non-competition); which, in the case of a material breach of the terms of this
Agreement or any other agreement, remains uncured for a period of fifteen (15) days following receipt of written notice from the
Board specifying the nature of such breach;

 

		(ii)	the commission by Executive of any act of embezzlement, fraud, larceny or theft on or from the
Company;

 

		(iii)	substantial and continuing neglect or inattention by Executive of the duties of his employment
or the willful misconduct or gross negligence of Executive in connection with the performance of such duties which remains uncured
for a period of fifteen (15) days following receipt of written notice from the Board specifying the nature of such breach; and

 

		(iv)	the commission and indictment by Executive of any crime involving moral turpitude or a felony.

 

		(b)	Termination for Good Reason. Executive shall have the right at any time to terminate Executive’s
employment with the Company upon not less than thirty (30) days prior written notice of termination for Good Reason (defined below).
For purposes of this Agreement and subject to the Company’s opportunity to cure as provided in Section 4(c) hereof, Executive
shall have Good Reason to terminate Executive’s employment hereunder if such termination shall be the result of:

 

		(i)	the Company’s material breach of this Agreement;

 

		(ii)	A requirement by the Company that Executive perform any act or refrain from performing any act
that would be in violation of any applicable law.

 

		(iii)	a material reduction in the responsibilities or reporting
relationship of Executive; or

 

		(iv)	a “Change of Control” which shall mean (a) the sale of all or substantially all of
the assets of the Company, (b) the dissolution or liquidation of the Company, or (c) any merger, share exchange, consolidation
or other reorganization or business combination of the Company if immediately after such transaction either (A) persons who were
directors of the Company immediately prior to such transaction do not constitute at least a majority of the directors of the surviving
entity, or (B) persons who hold over 50% of the voting capital stock of the surviving entity who are not persons who held voting
capital stock of the Company immediately prior to such transaction, provided, however, that a Change of Control shall
not include a public offering of capital stock of the Company. For purposes of this Section 4(b)(iv), a “person”
means any individual, entity or group within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934,
as amended, other than: employee benefit plans sponsored or maintained by the Company and corporations controlled by the Company.

  

    	3

    	 

    

 

		(c)	Notice and Opportunity to Cure. Notwithstanding the foregoing, it shall be a condition precedent
to the Company’s right to terminate Executive’s employment for Cause and Executive’s right to terminate for Good
Reason that (i) the party seeking termination shall first have given the other party written notice stating with specificity the
reason for the termination (“breach”) and (ii) if such breach is susceptible of cure or remedy, a period of fifteen
(15) days from and after the giving of such notice shall have elapsed without the breaching party having effectively cured or remedied
such breach during such 15-day period, unless such breach cannot be cured or remedied within fifteen (15) days, in which case the
period for remedy or cure shall be extended for a reasonable time (not to exceed an additional thirty (30) days) provided the breaching
party has made and continues to make a diligent effort to effect such remedy or cure. In case Executive is the party seeking termination,
written notice should be provided to the Company's Chairman of the Board or other members of the Board if the Executive is Chairman
of the Board.

 

		(d)	Voluntary Termination. Executive, at Executive’s election, may terminate Executive’s
employment upon not less than sixty (60) days prior written notice of termination other than for Good Reason.

 

		(e)	Termination Upon Death or Permanent and Total Disability. The Employment Period shall be
terminated by the death of Executive. The Employment Period may be terminated by the Board if Executive shall be rendered incapable
of performing Executive’s duties to the Company by reason of any medically determined physical or mental impairment that
can be reasonably expected to result in death or that can be reasonably be expected to last for a period of either (i) six (6)
or more consecutive months from the first date of Executive’s absence due to the disability or (ii) nine (9) months during
any twelve-month period (a “Permanent and Total Disability”). If the Employment Period is terminated by reason of a
Permanent and Total Disability of Executive, the Company shall give thirty (30) days’ advance written notice to that effect
to Executive.

 

		(f)	Termination at the Election of the Company. At the election of the Company, otherwise than
for Cause as set forth in Section 4(a) above, upon not less than sixty (60) days prior written notice of termination.

 

		(g)	Termination for Business Failure. Anything contained herein to the contrary notwithstanding,
in the event the Company’s business is discontinued because continuation is rendered impracticable by substantial financial
losses, lack of funding, legal decisions, administrative rulings, declaration of war, dissolution, national or local economic depression
or crisis or any reasons beyond the control of the Company, then this Agreement shall terminate as of the day the Company determines
to cease operation with the same force and effect as if such day of the month were originally set as the termination date hereof.
In the event this Agreement is terminated pursuant to this Section 4(g), the Company will give Executive fourteen (14) days’
advance written notice of termination and Executive will not be entitled to severance pay.

 

    	4

    	 

    

 

		5.	Consequences of Termination

 

		(a)	By Executive for Good Reason or by the Company Without Cause. In the event of a termination
of Executive’s employment during the Employment Period by Executive for Good Reason pursuant to Section 4(b) or by the Company
without Cause pursuant to Section 4(f) the Company shall pay Executive (or Executive’s estate) and provide Executive with
the following, provided that Executive enter into a release of claims agreement agreeable to the Company and Executive:

 

		(i)	Cash Payment. A lump-sum cash payment after Executive’s termination of employment,
equal to the sum of the following:

 

		(A)	Salary. $150,000; plus

 

		(B)	Earned but Unpaid Amounts. Any previously earned but unpaid salary through Executive’s
final date of employment with the Company, and any previously earned but unpaid bonus amounts prior to the date of Executive’s
termination of employment.

 

		(C)	Equity. All Equity vested at time of termination shall be retained by Executive and all
Equity that has not vested shall be accelerated and be deemed vested for purposes of this Section 5.

 

		(ii)	Other Benefits. The Company shall provide continued coverage for the Severance Period under
all health, life, disability and similar employee benefit plans and programs of the Company on the same basis as Executive was
entitled to participate immediately prior to such termination, provided that Executive’s continued participation is possible
under the general terms and provisions of such plans and programs. In the event that Executive’s participation in any such
plan or program is barred, the Company shall use its commercially reasonable efforts to provide Executive with benefits substantially
similar (including all tax effects) to those which Executive would otherwise have been entitled to receive under such plans and
programs from which his continued participation is barred. In the event that Executive is covered under substitute benefit plans
of another employer prior to the expiration of the Severance Period, the Company will no longer be obligated to continue the coverage
provided for in this Section 5(a)(ii).

 

    	5

    	 

    

 

		(b)	Other Termination of Employment. In the event that Executive’s employment with the
Company is terminated during the Employment Period by the Company for Cause (as provided for in Section 4(a) hereof) or by Executive
other than for Good Reason (as provided for in Section 4(b) hereof), the Company shall pay or grant Executive any earned but unpaid
salary, bonus, and Options through Executive’s final date of employment with the Company, and the Company shall have no further
obligations to Executive.

 

		(c)	Withholding of Taxes. All payments required to be made by the Company to Executive under
this Agreement shall be subject only to the withholding of such amounts, if any, relating to tax, excise tax and other payroll
deductions as may be required by law or regulation.

 

		(d)	No Other Obligations. The benefits payable to Executive under this Agreement are not in
lieu of any benefits payable under any employee benefit plan, program or arrangement of the Company, except as specifically provided
herein, and Executive will receive such benefits or payments, if any, as he may be entitled to receive pursuant to the terms of
such plans, programs and arrangements. Except for the obligations of the Company provided by the foregoing and this Section 5,
the Company shall have no further obligations to Executive upon his termination of employment.

 

		6.	Governing Law 

 

This Agreement and
the rights and obligations of the parties hereto shall be construed in accordance with the laws of the State of Delaware, without
giving effect to the principles of conflict of laws.

 

		7.	Indemnity and Insurance

 

The Company shall indemnify
and save harmless Executive for any liability incurred by reason of any act or omission performed by Executive while acting in
good faith on behalf of the Company and within the scope of the authority of Executive pursuant to this Agreement and to the fullest
extent provided under the Bylaws, the Certificate of Incorporation and the Delaware Revised Statutes, except that Executive must
have in good faith believed that such action was in, or not opposed to, the best interests of the Company, and, with respect to
any criminal action or proceeding, had no reasonable cause to believe that such conduct was unlawful.

 

The Company shall provide
that Executive is covered by any Directors and Officers insurance that the Company provides to other senior executives and/or board
members.

 

    	6

    	 

    

 

		8.	Cooperation with the Company After Termination of Employment

 

Following termination
of Executive’s employment for any reason, Executive shall fully cooperate with the Company in all matters relating to the
winding up of Executive’s pending work on behalf of the Company including, but not limited to, any litigation in which the
Company is involved, and the orderly transfer of any such pending work to other employees of the Company as may be designated by
the Company. Following any notice of termination of employment by either the Company or Executive, the Company shall be entitled
to such full time or part time services of Executive as the Company may reasonably require during all or any part of the sixty
(60)-day period following any notice of termination, provided that Executive shall be compensated for such services at the same
rate as in effect immediately before the notice of termination.

 

		9.	Notice

 

All notices, requests
and other communications pursuant to this Agreement shall be sent by overnight mail, by fax with proof of transmission or by email
with confirmed receipt to the following addresses:

 

If to Executive:

 

Phillip
E. Comans

Unit 6,
61 Avalon Parade

Avalon
Beach, NSW 2107

Australia

Phone:

Email:

 

If to the
Company:

 

Mariposa
Health, Inc.

888 Prospect Street

La Jolla, CA 92037

 

Attn: Kevin
Lynn, Vice President Finance

Phone:

Fax:

Email:

 

    	7

    	 

    

 

		10.	Waiver of Breach

 

Any waiver of any breach
of this Agreement shall not be construed to be a continuing waiver or consent to any subsequent breach on the part of either Executive
or of the Company.

 

		11.	Non-Assignment / Successors

 

Neither party hereto
may assign his/her or its rights or delegate his/hers or its duties under this Agreement without the prior written consent of the
other party; provided, however, that (i) this Agreement shall inure to the benefit of and be binding upon the successors and assigns
of the Company upon any sale or all or substantially all of the Company’s assets, or upon any merger, consolidation or reorganization
of the Company with or into any other corporation, all as though such successors and assigns of the Company and their respective
successors and assigns were the Company; and (ii) this Agreement shall inure to the benefit of and be binding upon the heirs, assigns
or designees of Executive to the extent of any payments due to them hereunder. As used in this Agreement, the term “Company”
shall be deemed to refer to any such successor or assign of the Company referred to in the preceding sentence.

 

		12.	Severability

 

To the extent any provision
of this Agreement or portion thereof shall be invalid or unenforceable, it shall be considered deleted there from and the remainder
of such provision and of this Agreement shall be unaffected and shall continue in full force and effect.

 

		13.	Counterparts

 

This Agreement may
be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together will constitute
one and the same instrument.

 

		14.	Arbitration

 

Executive and the Company
shall submit to mandatory and exclusive binding arbitration, any controversy or claim arising out of, or relating to, this Agreement
or any breach hereof where the amount in dispute is greater than or equal to $50,000, provided, however, that the
parties retain their right to, and shall not be prohibited, limited or in any other way restricted from, seeking or obtaining equitable
relief from a court having jurisdiction over the parties. In the event the amount of any controversy or claim arising out of, or
relating to, this Agreement, or any breach hereof, is less than $50,000, the parties hereby agree to submit such claim to mediation.
Such arbitration shall be governed by the Federal Arbitration Act and conducted through the American Arbitration Association (“AAA”)
in San Diego, California, before a single neutral arbitrator, in accordance with the National Rules for the Resolution of Employment
Disputes of the American Arbitration Association in effect at that time. The parties may conduct only essential discovery prior
to the hearing, as defined by the AAA arbitrator. The arbitrator shall issue a written decision which contains the essential findings
and conclusions on which the decision is based. Mediation shall be governed by, and conducted through, the AAA. Judgment upon the
determination or award rendered by the arbitrator may be entered in any court having jurisdiction thereof.

 

    	8

    	 

    

 

		15.	Entire Agreement

 

This Agreement and
all schedules and other attachments hereto constitute the entire agreement by the Company and Executive with respect to the subject
matter hereof and, except as specifically provided herein, supersedes any and all prior agreements or understandings between Executive
and the Company with respect to the subject matter hereof, whether written or oral. This Agreement may be amended or modified only
by a written instrument executed by Executive and the Company.

 

[Signature Page Follows]

 

    	9

    	 

    

  

IN WITNESS WHEREOF,
the parties have executed this Executive Employment Agreement as of the date above.

 

	 	MARIPOSA HEALTH, INC.
	 	 	 
	 	By:	/s/ Kevin Lynn
	 	 	Name: Kevin Lynn
	 	 	Title: Vice President Finance
	 	 	 
	 	EXECUTIVE
	 	 	 
	 	/s/ Phillip E. Comans
	 	Phillip E. Comans

 

    	10

    	 

    

 

Exhibit A

 

Proprietary Information
and Non-Competition Agreement

 

    	11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}]]